Related Experiment Video
Updated: Jul 24, 2025

07:14
Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae
Published on: February 25, 2022
6.0K
Disrupting pathologic phase transitions in neurodegeneration
Bryan T Hurtle1,2,3,4, Longxin Xie3,4,5, Christopher J Donnelly1,2,3,4
1Center for Neuroscience at the University of Pittsburgh Graduate Program.
The Journal of Clinical Investigation
|July 3, 2023
Summary
Protein deposits in the brain link to neurodegenerative diseases. Understanding liquid-liquid phase separation of proteins offers insights into cellular organization and potential therapeutic strategies for conditions like Alzheimer's disease.
Area of Science:
- Neuroscience
- Biochemistry
- Cell Biology
Background:
- Neurodegenerative diseases are characterized by abnormal protein deposits in the brain.
- These deposits, including tau and TDP-43, are linked to neurological deficits.
- Liquid-liquid phase separation (LLPS) is increasingly recognized as a key cellular mechanism.
Purpose of the Study:
- To explore the role of aberrant protein phase transitions in neurodegenerative diseases.
- To focus on tau and TDP-43 proteinopathies.
- To outline potential therapeutic strategies targeting these pathologic events.
Main Methods:
- Review of recent evidence on biomolecular phase transitions.
- Analysis of mechanisms contributing to aberrant protein phase transitions.
- Examination of protein signatures and depositions in neurodegenerative diseases.
Main Results:
- Pathologic proteins can assemble into liquid-like phases via LLPS.
- LLPS is a fundamental mechanism for cellular organization.
- Aberrant protein phase transitions are implicated in neuropathology.
Conclusions:
- Understanding LLPS enhances knowledge of molecular mechanisms in neurodegeneration.
- Targeting aberrant protein phase transitions presents potential therapeutic avenues.
- Further research into tau and TDP-43 proteinopathies is warranted.
Related Concept Videos
Parkinson's Disease: Overview
606
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
606
Alzheimer's Disease: Overview
527
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
527

